MAAS:NASDAQMaase Inc. Analysis
Data as of 2026-05-24 - not real-time
$11.85
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Maase Inc. is trading well above its 20‑day and 50‑day simple moving averages, indicating a strong bullish price momentum, while the 14‑day RSI has climbed to the high‑70s, signaling an overbought condition that could invite a short‑term correction. Technical indicators such as a bullish MACD crossover and a modest positive histogram support the upward trend, but the decreasing volume trend suggests weakening buying pressure. Fundamentally, the company reports zero revenue growth, negative operating and profit margins, and a trailing EPS of -3.21, underscoring severe earnings weakness. The DCF fair‑value estimate of less than one cent per share contrasts sharply with the current market price near $12, implying a massive valuation disconnect. A beta of approximately 2.7 and a 30‑day volatility exceeding 140% highlight extreme price swings, while a max drawdown of over 70% reflects historical downside risk. No dividend is paid, eliminating any income component for investors.
Regulatory and geographic considerations add further layers of uncertainty: operating in China's asset‑management sector exposes the firm to heightened regulatory scrutiny and policy shifts. The lack of cash reserves and the presence of a modest free cash flow stream do not offset the negative cash‑flow conversion from operations. Overall, while the price action appears bullish, the underlying financial health and risk profile are profoundly weak, making the stock a speculative play at best.
Regulatory and geographic considerations add further layers of uncertainty: operating in China's asset‑management sector exposes the firm to heightened regulatory scrutiny and policy shifts. The lack of cash reserves and the presence of a modest free cash flow stream do not offset the negative cash‑flow conversion from operations. Overall, while the price action appears bullish, the underlying financial health and risk profile are profoundly weak, making the stock a speculative play at best.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 7/10
Key Factors
- Overbought RSI suggesting near‑term pullback
- Decreasing volume undermining momentum
- Extreme price volatility and high beta
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Technical bullish trend may sustain price levels
- Fundamental earnings deficits remain unresolved
- Regulatory and geographic headwinds persist
Long Term
> 3 yearsCautious
Model confidence: 8/10
Key Factors
- Severe valuation gap versus DCF fair value
- Negative margins and zero revenue growth
- High regulatory and geopolitical risk in China
Key Metrics & Analysis
Financial Health
Profit Margin-50.96%
ROE-0.19%
ROA-0.13%
P/B Ratio0.0
Op. Cash Flow$10.2M
Free Cash Flow$230.0K
Industry P/E16.8
Technical Analysis
TrendBullish
RSI70.0
Support$8.56
Resistance$12.70
MA 20$9.87
MA 50$7.93
MA 200$5.32
MACDBullish
VolumeDecreasing
Fear & Greed Index91.61
Valuation
Fair Value$0.01
GradeOvervalued
TypeGrowth
Risk Assessment
Beta2.69
Volatility143.08%
Sector RiskMedium
Reg. RiskHigh
Geo RiskHigh
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.